Main sector:
Pharma (fully integrated)
Subsectors:
Antibodies
Drug delivery
Nucleic acid drugs
Peptides
Proteins
Small molecule therapeutics
Stem cells
Immunotherapy
Indications:
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Diseases of the nervous system / neurology
Cardiovascular / cardiology
Digestive system / gastroenterology
Genitourinary system / Urology
Pregnancy, childbirth and the puerperium / obstetrics
Congenital malformations, deformations and chromosomal abnormalities / medical genetics
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Social circumstances / substance related disorders / addiction
Products
In development: 36
On the market: 7
Description:
Novo Nordisk is a healthcare company that designs and manufactures pharmaceutical products. The company operates through two segments: Diabetes and Obesity care and biopharm. The diabetes and obesity care segment covers insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The biopharma segment covers the therapy areas of hemophilia, growth disorders, and hormone replacement therapy.
